Chemerin is not associated with subclinical atherosclerosis markers in prediabetes and diabetes

Chemerin was not found as an independent risk factor for predicting atherosclerosis in diabetes and prediabetes.Conclusion: Chemerin is not a predictive marker for atherosclerosis in diabetes and prediabetes, but correlates well with key aspects of the metabolic syndrome particularly in diabetes

📌 3 Maddede Bu Makale

🎯

Amaç & Hipotez:Objective: Chemerin is a novel adipokine that is correlated with adipocyte differentiation, glucose metabolism, and inflammation.

📊

Temel Bulgular & Veri:We aimed to investigate the relation between serum chemerin level and subclinical atherosclerosis markers as exemplified by brachial artery pulse wave velocity (baPWV), carotid intima-media thickness (CIMT), epicardial fat thickness (EFT), and carotid plaque presence in diabetes and prediabetes.Methods: Age-, body mass index (BMI)-, and gender-matched patients with type 2 DM (n=30), prediabetes (n=25), and normal glucose tolerance (n=25) were included in this cross-sectional study.

💡

Sonuç & Katkı:Chemerin was not found as an independent risk factor for predicting atherosclerosis in diabetes and prediabetes.Conclusion: Chemerin is not a predictive marker for atherosclerosis in diabetes and prediabetes, but correlates well with key aspects of the metabolic syndrome particularly in diabetes

🔬Tür:Araştırma Makalesi

📍Kapsam:Genişletilmiş Akademik Örneklem

⚙️Değişkenler:Alan Parametreleri

Abstract

Objective: Chemerin is a novel adipokine that is correlated with adipocyte differentiation, glucose metabolism, and inflammation. We aimed to investigate the relation between serum chemerin level and subclinical atherosclerosis markers as exemplified by brachial artery pulse wave velocity (baPWV), carotid intima-media thickness (CIMT), epicardial fat thickness (EFT), and carotid plaque presence in diabetes and prediabetes.Methods: Age-, body mass index (BMI)-, and gender-matched patients with type 2 DM (n=30), prediabetes (n=25), and normal glucose tolerance (n=25) were included in this cross-sectional study. Serum chemerin level, lipid parameters, glucose metabolism marker, baPWV, CIMT, EFT, and anthropometric were recorded. The independent risk factors for atherosclerosis markers were determined by linear and/or multiple logistic regression analysis.Results: baPWV and carotid plaque presence were higher in the diabetes group than in prediabetes and control groups (p=0.039 and p=0.035 respectively), whereas serum chemerin levels were similar among groups (p=0.338). Chemerin levels were not correlated with PWV, CIMT, and epicardial fat thickness overall or in the subgroups. Overall and in the diabetes group, chemerin levels were positively correlated with the key components of metabolic syndrome as BMI, total body fat percentage, waist circumference, triglyceride, and systolic and diastolic blood pressure (BP). After adjusting for age, gender, and BMI, only the association between chemerin and systolic BP remained significant. Chemerin was not found as an independent risk factor for predicting atherosclerosis in diabetes and prediabetes.Conclusion: Chemerin is not a predictive marker for atherosclerosis in diabetes and prediabetes, but correlates well with key aspects of the metabolic syndrome particularly in diabetes

🔖

Bu Makaleye Atıf Yap

TEZCAN, K. A., CANPOLAT, U., AKIN, Ş., DURAL, M., KARAKAYA, J., AYTEMİR, K., ÖZER, N., GÜRLEK, A. (2016). Chemerin is not associated with subclinical atherosclerosis markers in prediabetes and diabetes. The Anatolian Journal of Cardiology, Cilt: 16 - Sayı: 10, 749–755. https://ajindex.com/articles/365876

📄 Tam Metin PDF Okuyucu

Yeni Sekmede Aç ↗

↗Yeni Sekme

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (11)

Rajala MW, Scherer PE. Minireview: The adipocyte-at the cross- roads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology 2003; 144: 3765-73.
Ernst MC, Sinal CJ. Chemerin: at the crossroads of inflammation and obesity. Trends Endocrinol Metab 2010; 21: 660-7.
Bozaoğlu K, Bolton K, McMillan J, Zimmet P, Jowett J, Collier G, et al. Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology 2007; 148: 4687-94.
Goralski KB, McCarthy TC, Hanniman EA, Zabel BA, Butcher EC, Parlee SD, et al. Chemerin, a novel adipokine that regulates adipo- genesis and adipocyte metabolism. J Biol Chem 2007;282:28175-88.
Parlee SD, McNeil JO, Muruganandan S, Sinal CJ, Goralski KB. Elastase and tryptase govern TNF alpha-mediated production of active chemerin by adipocytes. PLoS One 2012; 7: 51072. Wittamer V, Franssen JD, Vulcano M, Mirjolet JF, Le Poul E, Mi- geotte I, et al. Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory flu- ids. J Exp Med 2003; 198: 977-85.
Hart R, Greaves DR. Chemerin contributes to inflammation by pro- moting macrophage adhesion to VCAM-1 and fibronectin through clustering of VLA-4 and VLA-5. J Immunol 2010; 185: 3728-39.
Becker M, Rabe K, Lebherz C, Zugwurst J, Goke B, Parhofer KG, et al. Expression of human chemerin induces insulin resistance in the skeletal muscle but does not affect weight, lipid levels, and athero- sclerosis in LDL receptor knockout mice on high-fat diet. Diabetes 2010; 59: 2898-903.
Sell H, Laurencikiene J, Taube A, Eckardt K, Cramer A, Horrighs A, et al. Chemerin is a novel adipocyte-derived factor inducing insulin resistance in primary human skeletal muscle cells. Diabetes 2009; 58: 2731-40.
Takahashi M, Okimura Y, Iguchi G, Nishizawa H, Yamamoto M, Suda K, et al. Chemerin regulates beta-cell function in mice. Sci Rep 2011; 1: 123. Bozaoğlu K, Curran JE, Stocker CJ, Zaibi MS, Segal D, Konstanto- poulos N, et al. Chemerin, a novel adipokine in the regulation of angiogenesis. J Clin Endocrinol Metab 2010; 95: 2476-85.
Gao X, Mi S, Zhang F, Gong F, Lai Y, Gao F, et al. Association of chemerin mRNA expression in human epicardial adipose tissue with coronary atherosclerosis. Cardiovasc Diabetol 2011; 10: 87. Spiroglou SG, Kostopoulos CG, Varakis JN, Papadaki HH. Adipo- kines in periaortic and epicardial adipose tissue: differential ex- pression and relation to atherosclerosis. J Atheroscler Thromb 2010; 17: 115-30.
Yoo HJ, C